Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism.
BACKGROUND: Familial isolated hyperparathyroidism (FIHP) is an autosomal dominant disorder characterized by uniglandular or multiglandular parathyroid tumours that occur in the absence of other endocrine tumours. The disorder may represent either an early stage of multiple endocrine neoplasia type 1...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2003
|
| _version_ | 1826258925125632000 |
|---|---|
| author | Pannett, A Kennedy, A Turner, J Forbes, SA Cavaco, B Bassett, J Cianferotti, L Harding, B Shine, B Flinter, F Maidment, C Trembath, R Thakker, R |
| author_facet | Pannett, A Kennedy, A Turner, J Forbes, SA Cavaco, B Bassett, J Cianferotti, L Harding, B Shine, B Flinter, F Maidment, C Trembath, R Thakker, R |
| author_sort | Pannett, A |
| collection | OXFORD |
| description | BACKGROUND: Familial isolated hyperparathyroidism (FIHP) is an autosomal dominant disorder characterized by uniglandular or multiglandular parathyroid tumours that occur in the absence of other endocrine tumours. The disorder may represent either an early stage of multiple endocrine neoplasia type 1 (MEN1), or an allelic variant of MEN1, or a distinct entity involving another locus. We have explored these possibilities in seven families in whom primary hyperparathyroidism occurred as the sole endocrinopathy. METHODS: Seven FIHP families were ascertained and venous blood samples obtained from 35 members (17 affected and 18 unaffected) for DNA sequence analysis of the MEN1 gene. The mean (+/- SD) follow-up period in the 17 affected members was 15.06 (+/- 8.83) years. RESULTS: Four heterozygous germline mutations of the MEN1 gene were identified. These consisted of two 4-bp intragenic deletions that would result in prematurely truncated proteins, and two missense (Asp153Val and Ala411Pro) mutations. Furthermore, analysis of parathyroid tumour DNA from one individual revealed a loss of the wild-type allele and retention of the mutant allele, consistent with Knudson's 'two-hit' model of hereditary cancer and a tumour suppressor role for MEN1 in FIHP. CONCLUSIONS: Our results provide further support for FIHP being a distinct allelic variant of MEN1, and an analysis of the 16 mutations reported to date indicate that FIHP is associated with a higher frequency of missense MEN1 mutations. |
| first_indexed | 2024-03-06T18:41:44Z |
| format | Journal article |
| id | oxford-uuid:0d15027a-b211-4015-a9da-17df9ce4288b |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T18:41:44Z |
| publishDate | 2003 |
| record_format | dspace |
| spelling | oxford-uuid:0d15027a-b211-4015-a9da-17df9ce4288b2022-03-26T09:38:44ZMultiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:0d15027a-b211-4015-a9da-17df9ce4288bEnglishSymplectic Elements at Oxford2003Pannett, AKennedy, ATurner, JForbes, SACavaco, BBassett, JCianferotti, LHarding, BShine, BFlinter, FMaidment, CTrembath, RThakker, RBACKGROUND: Familial isolated hyperparathyroidism (FIHP) is an autosomal dominant disorder characterized by uniglandular or multiglandular parathyroid tumours that occur in the absence of other endocrine tumours. The disorder may represent either an early stage of multiple endocrine neoplasia type 1 (MEN1), or an allelic variant of MEN1, or a distinct entity involving another locus. We have explored these possibilities in seven families in whom primary hyperparathyroidism occurred as the sole endocrinopathy. METHODS: Seven FIHP families were ascertained and venous blood samples obtained from 35 members (17 affected and 18 unaffected) for DNA sequence analysis of the MEN1 gene. The mean (+/- SD) follow-up period in the 17 affected members was 15.06 (+/- 8.83) years. RESULTS: Four heterozygous germline mutations of the MEN1 gene were identified. These consisted of two 4-bp intragenic deletions that would result in prematurely truncated proteins, and two missense (Asp153Val and Ala411Pro) mutations. Furthermore, analysis of parathyroid tumour DNA from one individual revealed a loss of the wild-type allele and retention of the mutant allele, consistent with Knudson's 'two-hit' model of hereditary cancer and a tumour suppressor role for MEN1 in FIHP. CONCLUSIONS: Our results provide further support for FIHP being a distinct allelic variant of MEN1, and an analysis of the 16 mutations reported to date indicate that FIHP is associated with a higher frequency of missense MEN1 mutations. |
| spellingShingle | Pannett, A Kennedy, A Turner, J Forbes, SA Cavaco, B Bassett, J Cianferotti, L Harding, B Shine, B Flinter, F Maidment, C Trembath, R Thakker, R Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism. |
| title | Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism. |
| title_full | Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism. |
| title_fullStr | Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism. |
| title_full_unstemmed | Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism. |
| title_short | Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism. |
| title_sort | multiple endocrine neoplasia type 1 men1 germline mutations in familial isolated primary hyperparathyroidism |
| work_keys_str_mv | AT pannetta multipleendocrineneoplasiatype1men1germlinemutationsinfamilialisolatedprimaryhyperparathyroidism AT kennedya multipleendocrineneoplasiatype1men1germlinemutationsinfamilialisolatedprimaryhyperparathyroidism AT turnerj multipleendocrineneoplasiatype1men1germlinemutationsinfamilialisolatedprimaryhyperparathyroidism AT forbessa multipleendocrineneoplasiatype1men1germlinemutationsinfamilialisolatedprimaryhyperparathyroidism AT cavacob multipleendocrineneoplasiatype1men1germlinemutationsinfamilialisolatedprimaryhyperparathyroidism AT bassettj multipleendocrineneoplasiatype1men1germlinemutationsinfamilialisolatedprimaryhyperparathyroidism AT cianferottil multipleendocrineneoplasiatype1men1germlinemutationsinfamilialisolatedprimaryhyperparathyroidism AT hardingb multipleendocrineneoplasiatype1men1germlinemutationsinfamilialisolatedprimaryhyperparathyroidism AT shineb multipleendocrineneoplasiatype1men1germlinemutationsinfamilialisolatedprimaryhyperparathyroidism AT flinterf multipleendocrineneoplasiatype1men1germlinemutationsinfamilialisolatedprimaryhyperparathyroidism AT maidmentc multipleendocrineneoplasiatype1men1germlinemutationsinfamilialisolatedprimaryhyperparathyroidism AT trembathr multipleendocrineneoplasiatype1men1germlinemutationsinfamilialisolatedprimaryhyperparathyroidism AT thakkerr multipleendocrineneoplasiatype1men1germlinemutationsinfamilialisolatedprimaryhyperparathyroidism |